ArticleGeoHealth2023
Temporal Relationships Between Saharan Dust Proxies, Climate, and Meningitis in Senegal.
Article in GeoHealth, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Review
- Profile of bacterial meningitis pathogens circulating in a cohort of school children in Côte d'Ivoire using 16S rRNA gene sequencing.BMC infectious diseases · 2026Article
- Prenatal Harmattan exposure and birth size: identifying sensitive windows in pregnancy.Frontiers in global women's health · 2026Article
- Desert Sand and Dust Storms and Desert Dust Episodes: Major Patterns to be Accounted for to Protect the Health of Exposed Population: A Review.ACS ES&T air · 2025Review
- Sand and dust storms: a growing global health threat calls for international health studies to support policy action.The Lancet. Planetary health · 2025Review
- The etiologies of Kawasaki disease.The Journal of clinical investigation · 2024Review
- Temporal Relationships Between Saharan Dust Proxies, Climate, and Meningitis in Senegal.GeoHealth · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Harmattan, a dry, northeasterly trade wind, transports large quantities of Saharan dust over the Sahelian region during the dry season (December-March). Studies have shown that bacterial meningitis outbreaks in Sahelian regions show hyper-endemic to endemic levels during high-dust months. We examine the (a) seasonality and intraseasonal variability of dust, climate, and meningitis and the (b) quantitative relationships between various dust proxies with meningitis lags of 0-10 weeks in Senegal from 2012 to 2017. The results show that the onset of the meningitis season occurs in February, roughly 2 months after the dusty season has begun. The meningitis season peaks at the beginning of April, when northeasterly wind speeds and particulate matter (PM) are relatively high, and the meningitis season ends near the end of June, when temperature and humidity rise and northeasterly wind speeds decline. Furthermore, we find that Senegal's relatively high humidity year-round may help slow the transmission of the infection, contributing to a lower disease incidence than landlocked countries in the meningitis belt. Lastly, our results suggest the desert dust may have a significant impact on the onset to the peak of the meningitis season in Senegal, particularly at the 0-2 and 10-week lag, whether that be directly through biological processes or indirectly through changes in human behavior. PM and visibility, however, are not in phase with aerosol optical depth throughout the year and consequently show different relationships with meningitis. This study further exemplifies the critical need for more PM, meteorological, and meningitis measurements in West Africa to further resolve these relationships.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.